ESC Premium Access

The ORION Program - Rationale and emerging evidence

Topic: Trial Design
Sponsored by the Medicines Company

Congress Presentation

About the speaker

Doctor David Kallend

The Medicines Company, Zurich (Switzerland)
1 presentation
0 follower

5 more presentations in this session

Welcome and introductions.

Speaker: Doctor B. Berkowitz (New York, US)


Atherosclerotic cardiovascular disease management has made significant progress but may have stalled recently.

Speaker: Doctor C. Gibson (Boston, US)


LDL-C and outcomes: Implementing 21st century cardiovascular trials

Speaker: Professor L. Bowman (Oxford, GB)


Another PCSK-9 therapy?

Speaker: Professor R. Wright (Rochester, US)


Approaches to critically assess the evidence. A checklist for ORION-11

Speaker: Doctor C. Gibson (Boston, US)


Access the full session

The ORION Program - What to look for in ORION-11

Speakers: Doctor D. Kallend, Doctor B. Berkowitz, Doctor C. Gibson, Professor L. Bowman, Professor R. Wright...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb